CDH5 and Hypertension: We demonstrated that the inhibition of VE-cadherin cleavage pathways by the three inhibitors used is associated with the prevention of IH-induced vascular remodeling, elastic fiber alteration atherosclerosis and hypertension in vivo, as well as endothelial permeability to LDL and monocytes in vitro.